The DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.
The Yin and Yang of HLA and KIR in human disease
Open accessAbstract
Killer cell immunoglobulin-like receptors (KIR) are expressed on natural killer (NK) cells and subsets of T cells. The KIR genes are polymorphic and the KIR gene complex is polygenic with varying numbers of inhibitory and activating receptors. HLA class I molecules serve as ligands for the KIR. Interactions of the independently segregating KIR and HLA loci are important for recognition of targets by NK cells as well as NK cell ‘licensing’. Several disease association studies indicate a role for interactions between these loci in infectious diseases, autoimmune/inflammatory disorders, cancer and reproduction. Emerging functional data supports a mechanism based on a continuum of inhibition to activation through various compound KIR-HLA genotypes in diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lanier, L. L. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115526 · Cited by 2,769
In search of the ‘missing self’: MHC molecules and NK cell recognition
Ljunggren, H.-G., & Kärre, K. (1990) · Immunology Today · doi:10.1016/0167-5699(90)90097-s · Cited by 2,687
Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy
Kärre, K., Ljunggren, H. G., Piontek, G., & Kiessling, R. (1986) · Nature · doi:10.1038/319675a0 · Cited by 2,161
Decidual NK cells regulate key developmental processes at the human fetal-maternal interface
Hanna, J., Goldman-Wohl, D., Hamani, Y., Avraham, I., Greenfield, C., Natanson-Yaron, S., Prus, D., Cohen-Daniel, L., Arnon, T. I., Manaster, I., et al. (2006) · Nature Medicine · doi:10.1038/nm1452 · Cited by 1,681
Licensing of natural killer cells by host major histocompatibility complex class I molecules
Kim, S., Poursine-Laurent, J., Truscott, S. M., Lybarger, L., Song, Y.-J., Yang, L., French, A. R., Sunwoo, J. B., Lemieux, S., Hansen, T. H., et al. (2005) · Nature · doi:10.1038/nature03847 · Cited by 1,340
Severe Herpesvirus Infections in an Adolescent without Natural Killer Cells
Biron, C. A., Byron, K. S., & Sullivan, J. L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198906293202605 · Cited by 1,269
Direct Recognition of Cytomegalovirus by Activating and Inhibitory NK Cell Receptors
Arase, H., Mocarski, E. S., Campbell, A. E., Hill, A. B., & Lanier, L. L. (2002) · Science · doi:10.1126/science.1070884 · Cited by 1,230
Human NK Cell Education by Inhibitory Receptors for MHC Class I
Anfossi, N., André, P., Guia, S., Falk, C. S., Roetynck, S., Stewart, C. A., Breso, V., Frassati, C., Reviron, D., Middleton, D., et al. (2006) · Immunity · doi:10.1016/j.immuni.2006.06.013 · Cited by 1,211
MHC class I molecules and kirs in human history, health and survival
Parham, P. (2005) · Nature Reviews Immunology · doi:10.1038/nri1570 · Cited by 1,203
Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS
Martin, M. P., Gao, X., Lee, J.-H., Nelson, G. W., Detels, R., Goedert, J. J., Buchbinder, S., Hoots, K., Vlahov, D., Trowsdale, J., et al. (2002) · Nature Genetics · doi:10.1038/ng934 · Cited by 1,189
Self-citationHLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus Infection
Khakoo, S. I., Thio, C. L., Martin, M. P., Brooks, C. R., Gao, X., Astemborski, J., Cheng, J., Goedert, J. J., Vlahov, D., Hilgartner, M., et al. (2004) · Science · doi:10.1126/science.1097670 · Cited by 1,179
Self-citationHiby, S. E., Walker, J. J., O'Shaughnessy, K. M., Redman, C. W. G., Carrington, M., Trowsdale, J., & Moffett, A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20041214 · Cited by 1,121
Self-citationInnate partnership of HLA-B and KIR3DL1 subtypes against HIV-1
Martin, M. P., Qi, Y., Gao, X., Yamada, E., Martin, J. N., Pereyra, F., Colombo, S., Brown, E. E., Shupert, W. L., Phair, J., et al. (2007) · Nature Genetics · doi:10.1038/ng2035 · Cited by 750
Self-citationValiante, N. M., Uhrberg, M., Shilling, H. G., Lienert-Weidenbach, K., Arnett, K. L., D'Andrea, A., Phillips, J. H., Lanier, L. L., & Parham, P. (1997) · Immunity · doi:10.1016/s1074-7613(00)80393-3 · Cited by 732
Rajagopalan, S., & Long, E. O. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.7.1093 · Cited by 726
Fernandez, N. C., Treiner, E., Vance, R. E., Jamieson, A. M., Lemieux, S., & Raulet, D. H. (2005) · Blood · doi:10.1182/blood-2004-08-3156 · Cited by 588
Yawata, M., Yawata, N., Draghi, M., Little, A.-M., Partheniou, F., & Parham, P. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051884 · Cited by 520
Gumperz, J. E., Litwin, V, Phillips, J. H., Lanier, L. L., & Parham, P. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.3.1133 · Cited by 509
MHC Class I Deficiency: Susceptibility to Natural Killer (NK) Cells and Impaired NK Activity
Liao, N.-S., Bix, M., Zijlstra, M., Jaenisch, R., & Raulet, D. (1991) · Science · doi:10.1126/science.1853205 · Cited by 490
Alter, G., Martin, M. P., Teigen, N., Carr, W. H., Suscovich, T. J., Schneidewind, A., Streeck, H., Waring, M., Meier, A., Brander, C., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070695 · Cited by 455
Self-citationWinter, C. C., Gumperz, J. E., Parham, P., Long, E. O., & Wagtmann, N. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.2.571 · Cited by 422
Recognition of peptide–MHC class I complexes by activating killer immunoglobulin-like receptors
Stewart, C. A., Laugier-Anfossi, F., Vély, F., Saulquin, X., Riedmuller, J., Tisserant, A., Gauthier, L., Romagné, F., Ferracci, G., Arosa, F. A., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503594102 · Cited by 406
Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand
Boyington, J. C., Motyka, S. A., Schuck, P., Brooks, A. G., & Sun, P. D. (2000) · Nature · doi:10.1038/35014520 · Cited by 404
Human uterine leukocytes and pregnancy
Trundley, A., & Moffett, A. (2004) · Tissue Antigens · doi:10.1111/j.1399-0039.2004.00170.x · Cited by 386
Hsu, K. C., Liu, X.-R., Selvakumar, A., Mickelson, E., O’Reilly, R. J., & Dupont, B. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.9.5118 · Cited by 381
Moesta, A. K., Norman, P. J., Yawata, M., Yawata, N., Gleimer, M., & Parham, P. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.6.3969 · Cited by 379
A human killer inhibitory receptor specific for HLA-A1,2
Döhring, C., Scheidegger, D., Samaridis, J., Cella, M., & Colonna, M. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.9.3098 · Cited by 349
Cella, M., Longo, A., Ferrara, G. B., Strominger, J. L., & Colonna, M. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.4.1235 · Cited by 340
Yen, J.-H., Moore, B. E., Nakajima, T., Scholl, D., Schaid, D. J., Weyand, C. M., & Goronzy, J. J. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.10.1159 · Cited by 335
Hiby, S. E., Regan, L., Lo, W., Farrell, L., Carrington, M., & Moffett, A. (2008) · Human Reproduction · doi:10.1093/humrep/den011 · Cited by 334
Self-citationMartin, M. P., Nelson, G., Lee, J.-H., Pellett, F., Gao, X., Wade, J., Wilson, M. J., Trowsdale, J., Gladman, D., & Carrington, M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.6.2818 · Cited by 328
Self-citationRecognition of HLA‐A3 and HLA‐A11 by KIR3DL2 is peptide‐specific
Hansasuta, P., Dong, T., Thananchai, H., Weekes, M., Willberg, C., Aldemir, H., Rowland‐Jones, S., & Braud, V. M. (2004) · European Journal of Immunology · doi:10.1002/eji.200425089 · Cited by 318
Peptide Specificity in the Recognition of MHC Class I by Natural Killer Cell Clones
Malnati, M. S., Peruzzi, M., Parker, K. C., Biddison, W. E., Ciccone, E., Moretta, A., & Long, E. O. (1995) · Science · doi:10.1126/science.7863326 · Cited by 309
KIR and disease: a model system or system of models?
Khakoo, S. I., & Carrington, M. (2006) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00459.x · Cited by 280
Self-citationRapid Evolution of NK Cell Receptor Systems Demonstrated by Comparison of Chimpanzees and Humans
Khakoo, S. I., Rajalingam, R., Shum, B. P., Weidenbach, K., Flodin, L., Muir, D. G., Canavez, F., Cooper, S. L., Valiante, N. M., Lanier, L. L., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)80219-8 · Cited by 277
Nelson, G. W., Martin, M. P., Gladman, D., Wade, J., Trowsdale, J., & Carrington, M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.7.4273 · Cited by 276
Self-citationHöglund, P., Ohlén, C., Carbone, E., Franksson, L., Ljunggren, H. G., Latour, A., Koller, B., & Kärre, K. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.22.10332 · Cited by 271
Gardiner, C. M., Guethlein, L. A., Shilling, H. G., Pando, M., Carr, W. H., Rajalingam, R., Vilches, C., & Parham, P. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.5.2992 · Cited by 264
HLA alleles determine differences in human natural killer cell responsiveness and potency
Kim, S., Sunwoo, J. B., Yang, L., Choi, T., Song, Y.-J., French, A. R., Vlahiotis, A., Piccirillo, J. F., Cella, M., Colonna, M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712229105 · Cited by 259
Carrington, M., Wang, S., Martin, M. P., Gao, X., Schiffman, M., Cheng, J., Herrero, R., Rodriguez, A. C., Kurman, R., Mortel, R., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042158 · Cited by 231
Self-citationGlobal diversity and evidence for coevolution of KIR and HLA
Single, R. M., Martin, M. P., Gao, X., Meyer, D., Yeager, M., Kidd, J. R., Kidd, K. K., & Carrington, M. (2007) · Nature Genetics · doi:10.1038/ng2077 · Cited by 229
Self-citationCutting Edge: Allele-Specific and Peptide-Dependent Interactions between KIR3DL1 and HLA-A and HLA-B
Thananchai, H., Gillespie, G., Martin, M. P., Bashirova, A., Yawata, N., Yawata, M., Easterbrook, P., McVicar, D. W., Maenaka, K., Parham, P., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.1.33 · Cited by 228
Self-citationCooley, S., Xiao, F., Pitt, M., Gleason, M., McCullar, V., Bergemann, T. L., McQueen, K. L., Guethlein, L. A., Parham, P., & Miller, J. S. (2007) · Blood · doi:10.1182/blood-2006-07-036228 · Cited by 226
KIR3DL1 Polymorphisms That Affect NK Cell Inhibition by HLA-Bw4 Ligand
Carr, W. H., Pando, M. J., & Parham, P. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.8.5222 · Cited by 224
van der Slik, A. R., Koeleman, B. P. C., Verduijn, W., Bruining, G. J., Roep, B. O., & Giphart, M. J. (2003) · Diabetes · doi:10.2337/diabetes.52.10.2639 · Cited by 224
Raulet, D. H., Held, W., Correa, I., Dorfman, J. R., Wu, M., & Corral, L. (1997) · Immunological Reviews · doi:10.1111/j.1600-065x.1997.tb00938.x · Cited by 224
Unusual selection on the KIR3DL1/S1 natural killer cell receptor in Africans
Norman, P. J., Abi-Rached, L., Gendzekhadze, K., Korbel, D., Gleimer, M., Rowley, D., Bruno, D., Carrington, C. V. F., Chandanayingyong, D., Chang, Y.-H., et al. (2007) · Nature Genetics · doi:10.1038/ng2111 · Cited by 218
Biassoni, R., Pessino, A., Malaspina, A., Cantoni, C., Bottino, C., Sivori, S., Moretta, L., & Moretta, A. (1997) · European Journal of Immunology · doi:10.1002/eji.1830271203 · Cited by 213
Pando, M. J., Gardiner, C. M., Gleimer, M., McQueen, K. L., & Parham, P. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.12.6640 · Cited by 212
Abi-Rached, L., & Parham, P. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042558 · Cited by 211
Namekawa, T., Snyder, M. R., Yen, J.-H., Goehring, B. E., Leibson, P. J., Weyand, C. M., & Goronzy, J. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.2.1138 · Cited by 210
Strategies for target cell recognition by natural killer cells
Diefenbach, A., & Raulet, D. H. (2001) · Immunological Reviews · doi:10.1034/j.1600-065x.2001.1810114.x · Cited by 210
Rajagopalan, S., & Long, E. O. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.8.1523 · Cited by 206
Artavanis-Tsakonas, K., Eleme, K., McQueen, K. L., Cheng, N. W., Parham, P., Davis, D. M., & Riley, E. M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.10.5396 · Cited by 199
KIR2DS1-Positive NK Cells Mediate Alloresponse against the C2 HLA-KIR Ligand Group In Vitro
Chewning, J. H., Gudme, C. N., Hsu, K. C., Selvakumar, A., & Dupont, B. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.2.854 · Cited by 186
Jennes, W., Verheyden, S., Demanet, C., Adjé-Touré, C. A., Vuylsteke, B., Nkengasong, J. N., & Kestens, L. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.6588 · Cited by 180
Gumperz, J. E., Barber, L. D., Valiante, N. M., Percival, L., Phillips, J. H., Lanier, L. L., & Parham, P. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.11.5237 · Cited by 179
Morice, W. G., Kurtin, P. J., Leibson, P. J., Tefferi, A., & Hanson, C. A. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04201.x · Cited by 169
Functional Polymorphism of the KIR3DL1/S1 Receptor on Human NK Cells
O’Connor, G. M., Guinan, K. J., Cunningham, R. T., Middleton, D., Parham, P., & Gardiner, C. M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.1.235 · Cited by 162
Ravet, S., Scott-Algara, D., Bonnet, E., Tran, H. K., Tran, T., Nguyen, N., Truong, L. X., Theodorou, I., Barré-Sinoussi, F., Pancino, G., et al. (2007) · Blood · doi:10.1182/blood-2006-08-040238 · Cited by 161
Ahlenstiel, G., Martin, M. P., Gao, X., Carrington, M., & Rehermann, B. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32400 · Cited by 161
Self-citationCarrington, M. N., & Norman, P. J. (2003) · Cited by 159
Self-citationKikuchi-Maki, A., Catina, T. L., & Campbell, K. S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.7.3859 · Cited by 157
How Does the Maternal Immune System Contribute to the Development of Pre-eclampsia?
Moffett, A., & Hiby, S. E. (2007) · Placenta · doi:10.1016/j.placenta.2006.11.008 · Cited by 156
Łuszczek, W., Mańczak, M., Cisło, M., Nockowski, P., Wiśniewski, A., Jasek, M., & Kuśnierczyk, P. (2004) · Human Immunology · doi:10.1016/j.humimm.2004.05.008 · Cited by 155
Carr, W. H., Rosen, D. B., Arase, H., Nixon, D. F., Michaëlsson, J., & Lanier, L. L. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.2.647 · Cited by 149
Association of killer cell immunoglobulin‐like receptors with scleroderma
Momot, T., Koch, S., Hunzelmann, N., Krieg, T. M., Ulbricht, K. U., Schmidt, R. E., & Witte, T. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20216 · Cited by 141
Comparative genomic analysis, diversity and evolution of two KIR haplotypes A and B.
Martin, A. M., Kulski, J. K., Gaudieri, S., Witt, C., Freitas, E., Trowsdale, J., & Christiansen, F. (2004) · Gene · doi:10.1016/j.gene.2004.03.018 · Cited by 138
Suzuki, Y., Hamamoto, Y., Ogasawara, Y., Ishikawa, K., Yoshikawa, Y., Sasazuki, T., & Muto, M. (2004) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.22517.x · Cited by 135
Cutting Edge: Expansion of the KIR Locus by Unequal Crossing Over
Martin, M. P., Bashirova, A. A., Traherne, J. A., Trowsdale, J., & Carrington, M. N. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.5.2192 · Cited by 134
Self-citationNakajima, T., Goek, O., Zhang, X., Kopecky, S. L., Frye, R. L., Goronzy, J. J., & Weyand, C. M. (2003) · Circulation Research · doi:10.1161/01.res.0000082333.58263.58 · Cited by 127
Katz, G., Markel, G., Mizrahi, S., Arnon, T. I., & Mandelboim, O. (2001) · Journal of Immunology · doi:10.4049/jimmunol.166.12.7260 · Cited by 122
Identification of a human member of the Ly-49 multigene family
Westgaard, I. H., Berg, S. F., Ørstavik, S., Fossum, S., & Dissen, E. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199806)28:06<1839::aid-immu1839>3.0.co;2-e · Cited by 122
Identification of natural killer cell receptor phenotypes associated with leukemia
Verheyden, S., Bernier, M., & Demanet, C. (2004) · Leukemia · doi:10.1038/sj.leu.2403525 · Cited by 119
Romero, V. A., Azócar, J. A., Zúñiga, J., Clavijo, O. P., Terreros, D. A., Gu, X., Husain, Z., Chung, R. T., Amos, C. I., & Yunis, E. J. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.01.002 · Cited by 118
Zappacosta, F., Borrego, F., Brööks, A. G., Parker, K. C., & Coligan, J. E. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6313 · Cited by 115
MHC Class I-Independent Recognition of NK-Activating Receptor KIR2DS4
Katz, G., Gazit, R., Arnon, T. I., Gonen‐Gross, T., Tarcic, G., Markel, G., Gruda, R., Achdout, H., Drize, O., Merims, S., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.3.1819 · Cited by 115
Zambello, R., Falco, M., Chiesa, M. D., Trentin, L., Carollo, D., Castriconi, R., Cannas, G., Carlomagno, S., Cabrelle, A., Lamy, T., et al. (2003) · Blood · doi:10.1182/blood-2002-12-3898 · Cited by 111
Long, B. R., Ndhlovu, L. C., Oksenberg, J. R., Lanier, L. L., Hecht, F. M., Nixon, D. F., & Barbour, J. D. (2008) · Journal of Virology · doi:10.1128/jvi.02449-07 · Cited by 105
Karlsen, T. H., Boberg, K. M., Olsson, M., Sun, J., Senitzer, D., Bergquist, A. M., Schrumpf, E., Thorsby, E., & Lie, B. A. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.01.032 · Cited by 92
D’Ombrain, M. C., Voss, T. S., Maier, A. G., Pearce, J. A., Hansen, D. S., Cowman, A. F., & Schofield, L. (2007) · Cell Host & Microbe · doi:10.1016/j.chom.2007.06.012 · Cited by 83
Modulation of HLA expression in human cytomegalovirus immune evasion.
Lin, A., Xu, H., & Yan, W. (2007) · PubMed · Cited by 81
Cutting Edge: Molecular Cloning of a Killer Cell Ig-Like Receptor in the Mouse and Rat
Hoelsbrekken, S. E., Nylenna, Ø., Saether, P. C., Slettedal, I. Ö., Ryan, J. C., Fossum, S., & Dissen, E. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.5.2259 · Cited by 79
Epigenetic Control of Highly Homologous Killer Ig-Like Receptor Gene Alleles
Chan, H.-W., Miller, J. S., Moore, M. B., & Lutz, C. T. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.9.5966 · Cited by 79
Lack of the appropriate natural killer cell inhibitory receptors in women with spontaneous abortion
Varla-Leftherioti, M., Spyropoulou‐Vlachou, M., Keramitsoglou, T., Papadimitropoulos, M., Tsekoura, C., Graphou, O., Papadopoulou, C., Gerondi, M., & Stavropoulos‐Giokas, C. (2004) · Human Immunology · doi:10.1016/j.humimm.2004.10.005 · Cited by 78
Distinct HLA-C/KIR Genotype Profile Associates with Guttate Psoriasis
Holm, S. J., Sakuraba, K., Mallbris, L., Wolk, K., Ståhle, M., & Sánchez, F. O. N. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2005.23879.x · Cited by 76
Naumova, E. J., Mihaylova, A., Stoitchkov, K., Ivanova, M., Quin, L., & Toneva, M. (2004) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-004-0575-z · Cited by 76
HLA-C and Killer Cell Immunoglobulin-like Receptor Genes in Idiopathic Bronchiectasis
Boyton, R. J., Smith, J. D., Ward, R. D., Jones, M. C., Ozerovitch, L., Wilson, R., Rose, M. L., Trowsdale, J., & Altmann, D. M. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200501-124oc · Cited by 72
Expression of KIR2DL1 on the entire NK cell population: a possible novel immunodeficiency syndrome
Gazit, R., Garty, B., Monselise, Y., Hoffer, V., Finkelstein, Y., Markel, G., Katz, G., Hanna, J. H., Achdout, H., Gruda, R., et al. (2004) · Blood · doi:10.1182/blood-2003-11-3796 · Cited by 72
Identification of bidirectional promoters in the human KIR genes
Davies, G. E., Locke, S., Wright, P. W., Li, H., Hanson, R. J., Miller, J. S., & Anderson, S. K. (2007) · Genes and Immunity · doi:10.1038/sj.gene.6364381 · Cited by 71
Identification of the ancestral killer immunoglobulin-like receptor gene in primates
Sambrook, J., Bashirova, A. A., Andersen, H., Piatak, M., Vernikos, G. S., Coggill, P. C., Lifson, J. D., Carrington, M. N., & Beck, S. (2006) · BMC Genomics · doi:10.1186/1471-2164-7-209 · Cited by 70
Self-citationBesson, C., Roetynck, S., Williams, F., Orsi, L., Amiel, C., Lependeven, C., Antoni, G., Hermine, O., Brice, P., Fermé, C., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000406 · Cited by 64
Maternal KIR repertoire is not associated with recurrent spontaneous abortion
Witt, C. S., Goodridge, J. P., Gerbase‐DeLima, M., Daher, S., & Christiansen, F. (2004) · Human Reproduction · doi:10.1093/humrep/deh483 · Cited by 62
The expanded cattle KIR genes are orthologous to the conserved single-copy KIR3DX1 gene of primates
Guethlein, L. A., Abi‐Rached, L., Hammond, J. A., & Parham, P. (2007) · Immunogenetics · doi:10.1007/s00251-007-0214-x · Cited by 60
Natural killer cells and malaria
Roetynck, S., Baratin, M., Johansson, S., Lemmers, C., Vivier, É., & Ugolini, S. (2006) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00446.x · Cited by 60
Pascal, V., Yamada, E., Martin, M. P., Alter, G., Altfeld, M., Metcalf, J., Baseler, M., Adelsberger, J., Carrington, M., Anderson, S., et al. (2007) · Journal of Immunology · doi:10.4049/jimmunol.179.3.1625 · Cited by 59
Self-citationWang, S., Zhao, Y., Jiao, Y., Wang, L., Li, J., Cui, B., Xu, C., Shi, Y., & Chen, Z. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.06.125 · Cited by 58
Evolution of natural killer cell receptors
Mager, D. L., McQueen, K. L., Wee, V., & Freeman, J. (2001) · Current Biology · doi:10.1016/s0960-9822(01)00148-8 · Cited by 56
Impact of KIR/HLA ligand combinations on immune responses in malignant melanoma
Naumova, E. J., Mihaylova, A., Ivanova, M., & Mihailova, S. M. (2006) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-006-0151-9 · Cited by 53
Majorczyk, E., Pawlik, A., Łuszczek, W., Nowak, I., Wiśniewski, A., Jasek, M., & Kuśnierczyk, P. (2007) · Genes and Immunity · doi:10.1038/sj.gene.6364433 · Cited by 51
Hansen, D. S., D’Ombrain, M. C., & Schofield, L. (2007) · Current Opinion in Immunology · doi:10.1016/j.coi.2007.07.011 · Cited by 39
Study of KIR genes in tuberculosis patients
Méndez, A., Granda, H., Meenagh, A., Contreras, S., Zavaleta, R., Mendoza, M. F., Izquierdo, L., Sarmiento, M. E., Acosta, A., & Middleton, D. (2006) · Tissue Antigens · doi:10.1111/j.1399-0039.2006.00685.x · Cited by 35
Kitawaki, J., Xu, B., Ishihara, H., Fukui, M., Hasegawa, G., Nakamura, N., Mizuno, S., Ohta, M., Obayashi, H., & Honjo, H. (2007) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2007.00533.x · Cited by 29
Limited allelic diversity of stimulatory two-domain killer cell immunoglobulin-like receptors
Hou, L., Steiner, N., Chen, M., Belle, I., Kubit, A., Ng, J., & Hurley, C. K. (2008) · Human Immunology · doi:10.1016/j.humimm.2008.01.009 · Cited by 27
Investigation of KIR Gene Frequencies in Type 1 Diabetes Mellitus
Middleton, D., Halfpenny, I. A., Meenagh, A., Williams, F., Sivula, J., & Tuomilehto‐Wolf, E. (2006) · Human Immunology · doi:10.1016/j.humimm.2006.08.295 · Cited by 26
Price, P., Witt, C. S., Santis, D. D., & French, M. A. (2007) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31805b82a1 · Cited by 19
Paparistidis, N., Papadopoulou, C., Chioti, A., Papaioannou, D., Tsekoura, C., Keramitsoglou, T., Kontopoulou‐Antonopoulou, V., Agapitos, E., Balafoutas, C., & Varla-Leftherioti, M. (2008) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2007.00547.x · Cited by 3
Cited by
Natural Killer Cell Education and Tolerance
Orr, M. T., & Lanier, L. L. (2010) · Cell · doi:10.1016/j.cell.2010.08.031 · Cited by 441
The immunogenetics of multiple sclerosis: A comprehensive review
Hollenbach, J. A., & Oksenberg, J. R. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.06.010 · Cited by 420
Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell–mediated deletion
Peppa, D., Gill, U. S., Reynolds, G., Easom, N. J. W., Pallett, L. J., Schurich, A., Micco, L., Nebbia, G., Singh, H. D., Adams, D. H., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20121172 · Cited by 342
Emerging targets in cancer immunotherapy
Burugu, S., Dancsok, A. R., & Nielsen, T. O. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.10.001 · Cited by 314
The extensive polymorphism of KIR genes
Middleton, D., & Gonzelez, F. (2010) · Immunology · doi:10.1111/j.1365-2567.2009.03208.x · Cited by 300
Metadata
- Authors
- Kulkarni, S., Martin, M. P., & Carrington, M.
- Venue
- Seminars in Immunology
- Publisher
- Elsevier BV
- Published
- 2008-12
- Volume
- 20
- Issue
- 6
- Pages
- 343-352
- ISSN
- 1044-5323 (ISSN-L)
- OpenAlex
- W2122132317
- Cited by
- 363
- References
- 108
- FWCI
- 10.05
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.